KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares Repurchased
Ratios

Regeneron Pharmaceuticals (REGN) Shares Repurchased (2018 - 2025)

Regeneron Pharmaceuticals has reported Shares Repurchased over the past 8 years, most recently at $671.7 million for Q4 2025.

  • Quarterly results put Shares Repurchased at $671.7 million for Q4 2025, down 30.97% from a year ago — trailing twelve months through Dec 2025 was $3.4 billion (up 32.09% YoY), and the annual figure for FY2025 was $3.4 billion, up 32.09%.
  • Shares Repurchased for Q4 2025 was $671.7 million at Regeneron Pharmaceuticals, up from $664.0 million in the prior quarter.
  • Over the last five years, Shares Repurchased for REGN hit a ceiling of $1.1 billion in Q2 2025 and a floor of $166.4 million in Q3 2021.
  • Median Shares Repurchased over the past 5 years was $633.9 million (2024), compared with a mean of $600.3 million.
  • Biggest five-year swings in Shares Repurchased: tumbled 93.96% in 2021 and later soared 461.66% in 2022.
  • Regeneron Pharmaceuticals' Shares Repurchased stood at $866.9 million in 2021, then tumbled by 50.27% to $431.1 million in 2022, then plummeted by 32.96% to $289.0 million in 2023, then surged by 236.68% to $973.0 million in 2024, then plummeted by 30.97% to $671.7 million in 2025.
  • The last three reported values for Shares Repurchased were $671.7 million (Q4 2025), $664.0 million (Q3 2025), and $1.1 billion (Q2 2025) per Business Quant data.